Stoke Therapeutics Q4 Earnings Report Analysis
Monday, 25 March 2024, 22:02
Stoke Therapeutics Q4 Earnings Report
Stoke Therapeutics posted a GAAP EPS of -$0.60, exceeding estimates by $0.02, while the revenue of $2.8M missed expectations by $0.42M.
Key Points:
- Positive: Beat on GAAP EPS
- Negative: Miss on Revenue
The Q4 report highlights the company's financial performance and future outlook.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.